Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Giagounidis

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Der Internist|May 10, 2013
[Myelodysplastic syndromes]A Giagounidis
Lancet (London, England)|December 29, 2000
Patents for intellectual propertyS Schäfer, A A Giagounidis
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Prevention of postsplenectomy sepsisU Germing, A Giagounidis, C Strupp
Antibiotics and Chemotherapy|June 30, 2000
Serum and plasma parameters in clinical evaluation of neutropenic feverT Südhoff, A Giagounidis, M Karthaus
Der Radiologe|December 18, 2002
[Medicinal therapy of malignant lymphomas]C Aul, M Schroeder, A Giagounidis
Chemotherapy|February 15, 2000
Evaluation of neutropenic fever: value of serum and plasma parameters in clinical practiceT Südhoff, A Giagounidis, M Karthaus
International Journal of Hematology|August 16, 2001
Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statisticsC Aul, A Giagounidis, U Germing
Der Internist|January 19, 2010
[Myelodysplastic syndromes]C Aul, A Giagounidis, U Germing
Annals of Hematology|October 10, 2002
Evaluating the prognosis of patients with myelodysplastic syndromesC Aul, A Giagounidis, U Germing, et al.
European Journal of Medical Research|October 16, 1995
Erythrocyte indices as screening tests for the differentiation of microcytic anemiasM Burk, J Arenz, A A Giagounidis, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Der Internist|May 10, 2013
[Myelodysplastic syndromes]A Giagounidis
Lancet (London, England)|December 29, 2000
Patents for intellectual propertyS Schäfer, A A Giagounidis
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Prevention of postsplenectomy sepsisU Germing, A Giagounidis, C Strupp
Antibiotics and Chemotherapy|June 30, 2000
Serum and plasma parameters in clinical evaluation of neutropenic feverT Südhoff, A Giagounidis, M Karthaus
Der Radiologe|December 18, 2002
[Medicinal therapy of malignant lymphomas]C Aul, M Schroeder, A Giagounidis
Chemotherapy|February 15, 2000
Evaluation of neutropenic fever: value of serum and plasma parameters in clinical practiceT Südhoff, A Giagounidis, M Karthaus
International Journal of Hematology|August 16, 2001
Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statisticsC Aul, A Giagounidis, U Germing
Der Internist|January 19, 2010
[Myelodysplastic syndromes]C Aul, A Giagounidis, U Germing
Annals of Hematology|October 10, 2002
Evaluating the prognosis of patients with myelodysplastic syndromesC Aul, A Giagounidis, U Germing, et al.
European Journal of Medical Research|October 16, 1995
Erythrocyte indices as screening tests for the differentiation of microcytic anemiasM Burk, J Arenz, A A Giagounidis, et al.
Pageof 6